Masanobu Fujimoto is an expert in Endocrinology at Tottori University (Japan). Masanobu Fujimoto has authored 10 publications, the most recent in 2026. SLR score: 26 (community average: 125). How the SLR is computed.

LeadR Profile

Masanobu Fujimoto Tottori University Japan
26 ScienceLeadR Reputation 26
Network Map

Endocrinology

Subspecialties: Pediatrics - Public Health - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026

Source: PubMed

Tottori University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 10

Citations

Citations: 3 1st author: 0 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Earlier bedtime at 1.5 years is associated with greater height gain at 3 years of age: a nationwide birth cohort study of the Japan environment and children's study.
PMID 42851434 — parturition, sleep, cohort studies, public health, environment, child
Front Public Health20260
Use, efficacy, and safety of desmopressin for congenital nephrogenic diabetes insipidus in children: a nationwide survey.
PMID 41605691 — diabetes mellitus, arginine vasopressin, diabetes insipidus, nephrogenic, injections, deamino arginine vasopressin, safety, arginine, therapeutics, water deprivation, diabetes insipidus, child
Endocr J20260
Multidisciplinary Management of Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis 1: Insights From Advisory Board-Guided Clinical Experience in Japan.
PMID 41127924 — neurofibroma, drug-related side effects and adverse reactions, neurofibromatosis 1, neurofibromatoses, therapeutics, neurofibroma, plexiform, dermatology
J Dermatol20250
National survey of Hutchinson-Gilford progeria syndrome and progeroid laminopathy in Japan.
PMID 40644604 — progeria, laminopathies, aging, prevalence, diagnosis
Aging (Albany NY)20250
Clinical characteristics of and growth hormone treatment effects on short stature with type 1 insulin-like growth factor receptor (IGF1R) gene alteration.
PMID 38710621 — endocrinology, research design, genes, genetic testing, growth, insulin, serum, somatomedins, hormones, receptors, growth factor, therapeutics, growth hormone, receptors, somatomedin
Endocr J20242

LeadR Networks

Main global connection map